Granules India Limited is a pharmaceutical company headquartered in Hyderabad, India. The company was founded in 1984 by Mr. P.V. Appa Rao. Granules India is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company has two manufacturing facilities located in Hyderabad and Visakhapatnam, India. Granules India has a workforce of over 4,000 employees.
The company’s product portfolio includes over 300 formulations and 100 APIs. Granules India’s formulations are available in various dosage forms such as tablets, capsules, powders, liquids, and injectables. The company’s APIs are used in the manufacture of finished formulations by its customers.
Granules India has a strong presence in the Indian market with a market share of over 5% in the Indian pharmaceutical market. The company’s products are also exported to over 60 countries.
Granules India’s business strategy is focused on expanding its operations in the global market. The company plans to achieve this by investing in research and development, expanding its manufacturing capacity, and increasing its sales and marketing efforts. Granules India is also planning to list its shares on the stock exchange in the near future.
The website address of the company is www.granulesindia.com.